US 2020/0138939 A1 · VACCINE ADJUVANT COMPOSITION BASED ON AMPHIPHILIC POLYAMINO ACID POLYMER, CONTAINING SQUALENE

Abstract

The present invention relates to an immunoadjuvant composition that includes amphiphilic polymer particles in an oil-in-water emulsion state containing an amphiphilic poly-amino acid polymer and a method of preparing the same. Since the immunoadjuvant composition of the present invention is prepared using an amphiphilic poly-amino acid polymer, it allows the provision of a vaccine immunoadjuvant composition which is more biocompatible and has a high antibody titer.

Claims12

Dependent claims

An amphiphilic poly-amino acid polymer represented by Formula 1 below:

Wherein R1 is one selected from the group consisting of
and
x, y, and z are integers greater than 1.

Dependencies are inferred from the claim text.

Facts

Application

16/062,784Filed 15 Dec 2016

Priority

KR 10-2015-018041316 Dec 2015

Published

7 May 2020

Term ends

Not estimatedThe source records don’t support an estimate.

Classification29 codes

A61K 39/145
Viral antigens: orthomyxoviridae, e.g. influenza virus
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 9/0021
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in…

Vaccine adjuvant composition based on amphiphilic polyamino acid polymer, containing squalene

Life of this patent

Vaccine adjuvant composition based on amphiphilic polyamino acid polymer, containing squalene

Life of this patent

Abstract

Claims12